Stage pT0 in Radical Prostatectomy with No Residual Carcinoma and with a Previous Positive Biopsy Conveys a Wrong Message to Clinicians and Patients: Why Is Cancer Not Present in the Radical Prostatectomy Specimen?

European Urology

Volumn 56, Issue 2, 2009, Pages 272-274

  Montironi, Rodolfo ^a   Cheng, Liang ^b   Lopez Beltran, Antonio ^c   Scarpelli, Marina ^a   Mazzucchelli, Roberta ^a   Mikuz, Gregor ^d   Kirkali, Ziya ^e   Montorsi, Francesco ^f  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^d MEDICAL UNIVERSITY OF INNSBRUCK   (Austria)

^e DOKUZ EYLUL UNIVERSITY   (Turkey)

^f VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; EDITORIAL; HEALTH CARE PERSONNEL; HORMONAL THERAPY; HUMAN; MEDICAL ERROR; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA;

BIOPSY; HUMANS; MALE; NEOPLASM STAGING; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 67649427869     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2009.04.042     Document Type: Editorial

References (22)

1. Mazzucchelli R., Barbisan F., Tagliabracci A., et al. Search for residual prostate cancer on pT0 radical prostatectomy after prostate biopsy. Virchows Arch 450 (2007) 371-378
2. Goldstein N.S., Bégin L.R., Grody W.W., Novak J.M., Qian J., and Bostwick D.G. Minimal or no cancer in radical prostatectomy specimens: report of 13 cases of the "vanishing cancer phenomenon". Am J Surg Pathol 19 (1995) 1002-1009
3. Cao D., Hafez M., Berg K., Murphy K., and Epstein J.I. Little or no residual prostate cancer at radical prostatectomy: vanishing cancer or switched specimen? A microsatellite analysis of specimen identity. Am J Surg Pathol 29 (2005) 467-473
4. DiGiuseppe J.A., Sauvageot J., and Epstein J.I. Increasing incidence of minimal residual cancer in radical prostatectomy specimens. Am J Surg Pathol 21 (1997) 174-178
5. Truskinovsky A.M., Sanderson H., and Epstein J.I. Characterization of minute adenocarcinomas of prostate at radical prostatectomy. Urology 64 (2004) 733-737
6. Bostwick D.G., and Bostwick K.C. Vanishing" prostate cancer in radical prostatectomy specimens: incidence and long-term follow-up in 38 cases. BJU Int 94 (2004) 57-58
7. Trpkov K., Gao Y., Hay R., and Yimaz A. No residual cancer on radical prostatectomy after positive 10-core biopsy: incidence, biopsy findings, and DNA specimen identity analysis. Arch Pathol Lab Med 130 (2006) 811-816
8. Herkommer K., Kuefer R., Gschwend J.E., Hautmann R.E., and Volkmer B.G. Pathological T0 prostate cancer without neoadjuvant therapy: clinical presentation and follow-up. Eur Urol 45 (2004) 36-41
9. Descazeaud A., Zerbib M., Flam T., Vieillefond A., Debre B., and Peyromaure M. Can pT0 stage of prostate cancer be predicted before radical prostatectomy?. Eur Urol 50 (2006) 1248-1253
10. Hammerer P. pT0 after radical prostatectomy: overtreatment for insignificant prostate cancer?. Eur Urol 45 (2004) 35
11. Hellström M., Häggman M., Brändstedt S., et al. Histopathological changes in androgen-deprived localized prostatic cancer. A study in total prostatectomy specimens. Eur Urol 24 (1993) 461-465
12. Köllermann J., Feek U., Müller H., et al. Nondetected tumor (pT0) after prolonged, neoadjuvant treatment of localized prostatic carcinoma. Eur Urol 38 (2000) 714-720
13. Köllermann J., Hopfenmüller W., Caprano J., et al. Prognosis of stage pT0 after prolonged neoadjuvant endocrine therapy of prostate cancer: a matched-pair analysis. Eur Urol 45 (2004) 42-45
14. Murphy W.M., Soloway M.S., and Barrows G.H. Pathologic changes associated with androgen deprivation therapy for prostate cancer. Cancer 68 (1991) 821-828
15. Smith D.M., and Murphy W.M. Histologic changes in prostate carcinomas treated with leuprolide (luteinizing hormone-releasing hormone effect). Distinction from poor tumor differentiation. Cancer 73 (1994) 1472-1477
16. Tetu B., Srigley J.R., Boivin J.C., et al. Effect of combination endocrine therapy (LHRH agonist and flutamide) on normal prostate and prostatic adenocarcinoma. A histopathologic and immunohistochemical study. Am J Surg Pathol 15 (1991) 111-120
17. Prayer-Galetti T., Gardiman M., Sacco E., Fracalanza S., Betto G., and Pinto F. Finding of no tumor (pT0) in patients undergoing radical retropubic prostatectomy for clinically localized prostate cancer. Anal Quant Cytol Histol 29 (2007) 79-86
18. Duffield A.S., and Epstein J.I. Detection of cancer in radical prostatectomy specimens with no residual carcinoma in the issue review of slides. Am J Surg Pathol 33 (2009) 120-125
19. Cohen M.B., Soloway M.S., and Murphy W.M. Sampling of radical prostatectomy specimens. How much is adequate?. Am J Clin Pathol 101 (1994) 250-252
20. Humphrey P.A. Complete histologic serial sectioning of a prostate gland with adenocarcinoma. Am J Surg Pathol 17 (1993) 468-472
21. Heidenreich A., Aus G., Bolla M., et al. EAU guidelines on prostate cancer. Eur Urol 53 (2008) 68-80
22. Samaratunga H, True L, Montironi R. International Society of Urological Pathologists (ISUP) Consensus Conference on Handling of Radical Prostatectomy Specimens. Mod Pathol. In press.